FMED
Fidelity Disruptive Medicine ETF
Price Chart
Latest Quote
$28.83
+0.15 (+0.53%)
Current Price
| Previous Close | $28.68 |
| Open | $28.23 |
| Day High | $28.89 |
| Day Low | $28.23 |
| Volume | 3,724 |
Fund Information
| Net Assets | $46.40M |
| Expense Ratio | 0.50% |
| Category | Health |
| Fund Family | Fidelity Investments |
| Net Asset Value | $28.91 |
| Premium/Discount | -0.28% |
| P/E Ratio | 40.86 |
| Exchange | NGM |
đ ETF Analysis
Company Data
Financial Ratios
Returns & Margins
Ownership
| Insider & Institutional transactions data not available |
Valuation Ratios
Analyst Data
Technical Indicators
| SMA20 | $28.52 |
| SMA50 | $26.34 |
| SMA200 | $26.28 |
| RSI | 56.82 |
| ATR | 0.5491 |
| Rel Volume | 0.37 |
Performance History
| Week | -2.46% |
| Month | +12.16% |
| Quarter | +12.07% |
| 6 Months | +4.73% |
| YTD | +7.23% |
| Year | +21.12% |
| 3 Years | +16.50% |
| 10 Years | +14.58% |
ETF Scoring Not Available
Exchange-traded funds (ETFs) are not scored using our fundamental analysis metrics, as they represent baskets of securities rather than individual companies.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-07-17 | $28.83 | 3,700 |
| 2026-07-16 | $28.81 | 17,100 |
| 2026-07-15 | $29.17 | 5,600 |
| 2026-07-14 | $29.07 | 3,700 |
| 2026-07-13 | $29.07 | 25,500 |
| 2026-07-10 | $29.56 | 9,100 |
| 2026-07-09 | $30.10 | 5,800 |
| 2026-07-08 | $29.57 | 12,500 |
| 2026-07-07 | $29.99 | 12,900 |
| 2026-07-06 | $29.36 | 13,500 |
| 2026-07-02 | $29.38 | 21,200 |
| 2026-07-01 | $28.94 | 7,300 |
| 2026-06-30 | $28.52 | 11,700 |
| 2026-06-29 | $28.51 | 11,900 |
| 2026-06-26 | $28.25 | 7,700 |
| 2026-06-25 | $27.64 | 6,400 |
| 2026-06-24 | $26.99 | 5,400 |
| 2026-06-23 | $26.39 | 10,500 |
| 2026-06-22 | $26.12 | 4,900 |
| 2026-06-18 | $26.10 | 6,100 |
About Fidelity Disruptive Medicine ETF
The fund normally invests at least 80% of assets in securities of disruptive medicine companies. Fidelity's disruptive strategies seek to identify innovative developments that could signal new directions for delivering products and services to customers. Generally, these companies have or are developing new or unconventional ways of doing business that could disrupt and displace incumbents over time. The fund is non-diversified.
đ° Latest News
No news articles available at the moment. Check back later for updates on FMED.
Period:
Loading...
No financial data available yet. Financial data will be fetched automatically.